{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:18:55Z","timestamp":1783487935225,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10157-022-02241-w","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T12:03:49Z","timestamp":1654776229000},"page":"943-954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["RETRACTED ARTICLE: Circ_0000064 knockdown\n         attenuates high glucose-induced proliferation, inflammation and extracellular matrix\n         deposition of mesangial cells through miR-424-5p-mediated WNT2B inhibition in cell models\n         of diabetic nephropathy"],"prefix":"10.1007","volume":"26","author":[{"given":"Jianfei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"issue":"1\u20132","key":"2241_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1900\/RDS.2015.12.119","volume":"12","author":"E Dounousi","year":"2015","unstructured":"Dounousi E, et al. Improvements in the management of diabetic\n               nephropathy. Rev Diabet Stud. 2015;12(1\u20132):119\u201333.","journal-title":"Rev Diabet Stud"},{"issue":"9","key":"2241_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrendo.2012.125","volume":"8","author":"ME Cooper","year":"2012","unstructured":"Cooper ME. Diabetes: treating diabetic nephropathy-still an unresolved\n               issue. Nat Rev Endocrinol. 2012;8(9):515\u20136.","journal-title":"Nat Rev Endocrinol"},{"issue":"2 Suppl 2","key":"2241_CR3","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1053\/j.ajkd.2013.10.047","volume":"63","author":"SS Badal","year":"2014","unstructured":"Badal SS, Danesh FR. New insights into molecular mechanisms of diabetic\n               kidney disease. Am J Kidney Dis. 2014;63(2 Suppl 2):S63-83.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2241_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","volume":"87","author":"JE Shaw","year":"2010","unstructured":"Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of\n               diabetes for 2010 and 2030. Diabetes Res Clin Pract.\n               2010;87(1):4\u201314.","journal-title":"Diabetes Res Clin Pract"},{"key":"2241_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fphar.2020.00191","volume":"11","author":"TS Loganathan","year":"2020","unstructured":"Loganathan TS, et al. Interactions among non-coding RNAs in diabetic\n               nephropathy. Front Pharmacol. 2020;11:191.","journal-title":"Front Pharmacol"},{"issue":"4","key":"2241_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrm.2015.32","volume":"17","author":"LL Chen","year":"2016","unstructured":"Chen LL. The biogenesis and emerging roles of circular RNAs. Nat Rev\n               Mol Cell Biol. 2016;17(4):205\u201311.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2241_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","volume":"32","author":"WR Jeck","year":"2014","unstructured":"Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat\n               Biotechnol. 2014;32(5):453\u201361.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"2241_CR8","doi-asserted-by":"publisher","first-page":"21249","DOI":"10.1002\/jcp.28730","volume":"234","author":"B Chen","year":"2019","unstructured":"Chen B, et al. circLRP6 regulates high glucose-induced proliferation,\n               oxidative stress, ECM accumulation, and inflammation in mesangial cells. J Cell\n               Physiol. 2019;234(11):21249\u201359.","journal-title":"J Cell Physiol"},{"issue":"12","key":"2241_CR9","doi-asserted-by":"publisher","first-page":"8301","DOI":"10.1073\/pnas.122228799","volume":"99","author":"FR Danesh","year":"2002","unstructured":"Danesh FR, et al. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors\n               prevent high glucose-induced proliferation of mesangial cells via modulation of Rho\n               GTPase\/ p21 signaling pathway: Implications for diabetic nephropathy. Proc Natl Acad\n               Sci U S A. 2002;99(12):8301\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2241_CR10","doi-asserted-by":"crossref","unstructured":"Sharma, K. and F.N. Ziyadeh, Hyperglycemia and\n                  diabetic kidney disease. The case for transforming growth factor-beta as a key\n                  mediator. Diabetes, 1995. 44(10): p.\n               1139\u201346.","DOI":"10.2337\/diabetes.44.10.1139"},{"issue":"2","key":"2241_CR11","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/jcp.26959","volume":"234","author":"W Hu","year":"2019","unstructured":"Hu W, et al. Circular RNA circRNA_15698 aggravates the extracellular\n               matrix of diabetic nephropathy mesangial cells via miR-185\/TGF-beta1. J Cell Physiol.\n               2019;234(2):1469\u201376.","journal-title":"J Cell Physiol"},{"key":"2241_CR12","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.biopha.2017.12.015","volume":"96","author":"YH Luo","year":"2017","unstructured":"Luo YH, et al. Emerging roles of circular RNA hsa_circ_0000064 in the\n               proliferation and metastasis of lung cancer. Biomed Pharmacother.\n               2017;96:892\u20138.","journal-title":"Biomed Pharmacother"},{"key":"2241_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144952","volume":"758","author":"X Ge","year":"2020","unstructured":"Ge X, et al. Circular RNA Circ_0000064 promotes the proliferation and\n               fibrosis of mesangial cells via miR-143 in diabetic nephropathy. Gene. 2020;758:\n               144952.","journal-title":"Gene"},{"issue":"7441","key":"2241_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, et al. Natural RNA circles function as efficient microRNA\n               sponges. Nature. 2013;495(7441):384\u20138.","journal-title":"Nature"},{"key":"2241_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.586814","volume":"11","author":"Q Sun","year":"2020","unstructured":"Sun Q, et al. Differential Expression and Bioinformatics Analysis of\n               circRNA in Non-small Cell Lung Cancer. Front Genet. 2020;11:\n               586814.","journal-title":"Front Genet"},{"issue":"7","key":"2241_CR16","doi-asserted-by":"publisher","first-page":"11646","DOI":"10.1002\/jcp.27822","volume":"234","author":"G Wang","year":"2019","unstructured":"Wang G, et al. Upregulation of microRNA-424 relieved diabetic\n               nephropathy by targeting Rictor through mTOR Complex2\/Protein Kinase B signaling. J\n               Cell Physiol. 2019;234(7):11646\u201353.","journal-title":"J Cell Physiol"},{"issue":"7","key":"2241_CR17","first-page":"2435","volume":"12","author":"XJ Zhu","year":"2019","unstructured":"Zhu XJ, et al. Long non-coding RNA Hottip modulates\n               high-glucose-induced inflammation and ECM accumulation through miR-455-3p\/WNT2B in\n               mouse mesangial cells. Int J Clin Exp Pathol. 2019;12(7):2435\u201345.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"2241_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12943-017-0719-3","volume":"16","author":"J Zhang","year":"2017","unstructured":"Zhang J, et al. Circular RNA_LARP4 inhibits cell proliferation and\n               invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression.\n               Mol Cancer. 2017;16(1):151.","journal-title":"Mol Cancer"},{"issue":"5","key":"2241_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2174\/1389450115666140321120635","volume":"15","author":"MK Arora","year":"2014","unstructured":"Arora MK, Singh UK. Oxidative stress: meeting multiple targets in\n               pathogenesis of diabetic nephropathy. Curr Drug Targets.\n               2014;15(5):531\u20138.","journal-title":"Curr Drug Targets"},{"key":"2241_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144971","volume":"761","author":"W Wang","year":"2020","unstructured":"Wang W, et al. Circ_0123996 promotes cell proliferation and fibrosisin\n               mouse mesangial cells through sponging miR-149-5p and inducing Bach1 expression.\n               Gene. 2020;761: 144971.","journal-title":"Gene"},{"issue":"21","key":"2241_CR21","first-page":"9321","volume":"23","author":"L Wu","year":"2019","unstructured":"Wu L, et al. Circ_0000064 adsorption of microRNA-143 promotes malignant\n               progression of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci.\n               2019;23(21):9321\u201330.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2241_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107715","volume":"220","author":"F Saaoud","year":"2021","unstructured":"Saaoud F, et al. Circular RNAs are a novel type of non-coding RNAs in\n               ROS regulation, cardiovascular metabolic inflammations and cancers. Pharmacol Ther.\n               2021;220: 107715.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2241_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-021-01318-6","volume":"20","author":"F Long","year":"2021","unstructured":"Long F, et al. Comprehensive landscape and future perspectives of\n               circular RNAs in colorectal cancer. Mol Cancer. 2021;20(1):26.","journal-title":"Mol Cancer"},{"issue":"11","key":"2241_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41419-021-04339-7","volume":"12","author":"ZH Feng","year":"2021","unstructured":"Feng ZH, et al. EIF4A3-induced circular RNA PRKAR1B promotes\n               osteosarcoma progression by miR-361-3p-mediated induction of FZD4 expression. Cell\n               Death Dis. 2021;12(11):1025.","journal-title":"Cell Death Dis"},{"issue":"4","key":"2241_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/neuonc\/noaa214","volume":"23","author":"Y Wei","year":"2021","unstructured":"Wei Y, et al. EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis\n               and temozolomide resistance of glioblastoma via NRAS\/MEK1\/ERK1-2 signaling. Neuro\n               Oncol. 2021;23(4):611\u201324.","journal-title":"Neuro Oncol"},{"issue":"24","key":"2241_CR26","doi-asserted-by":"publisher","first-page":"10908","DOI":"10.7150\/thno.48264","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, et al. Circular RNA circPPM1F modulates M1 macrophage\n               activation and pancreatic islet inflammation in type 1 diabetes mellitus.\n               Theranostics. 2020;10(24):10908\u201324.","journal-title":"Theranostics."},{"issue":"11","key":"2241_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073798","volume":"8","author":"F Barutta","year":"2013","unstructured":"Barutta F, et al. Urinary exosomal microRNAs in incipient diabetic\n               nephropathy. PLoS ONE. 2013;8(11): e73798.","journal-title":"PLoS ONE"},{"key":"2241_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109622","volume":"121","author":"Y Li","year":"2020","unstructured":"Li Y, et al. LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation\n               and extracellular matrix accumulation via miR-424-5p\/HMGA2 axis. Biomed Pharmacother.\n               2020;121: 109622.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2241_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4161\/org.4.2.5849","volume":"4","author":"K Pulkkinen","year":"2008","unstructured":"Pulkkinen K, Murugan S, Vainio S. Wnt signaling in kidney development\n               and disease. Organogenesis. 2008;4(2):55\u20139.","journal-title":"Organogenesis"},{"issue":"1","key":"2241_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13098-020-00618-z","volume":"12","author":"J Chang","year":"2020","unstructured":"Chang J, et al. Long non-coding RNA CDKN2B-AS1 regulates high\n               glucose-induced human mesangial cell injury via regulating the miR-15b-5p\/WNT2B axis.\n               Diabetol Metab Syndr. 2020;12(1):109.","journal-title":"Diabetol Metab Syndr"}],"updated-by":[{"DOI":"10.1007\/s10157-024-02619-y","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000}}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02241-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-022-02241-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02241-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T07:21:13Z","timestamp":1735888873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-022-02241-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["2241"],"URL":"https:\/\/doi.org\/10.1007\/s10157-022-02241-w","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10157-024-02619-y","URL":"https:\/\/doi.org\/10.1007\/s10157-024-02619-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial conflicts of\n               interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was approved by the ethical review committee of\n               Liuzhou People\u2019s Hospital. Written informed consent was obtained from all enrolled\n               patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients agreed to participate in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}